SGAM
NEO icon

Smith Group Asset Management’s NeoGenomics NEO Stock Holding History

Smith Group Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-99,800
Closed -$1.26M – 464
2018
Q4 		$1.26M Buy
+99,800
New +$1.49M 0.04% 156

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Smith Group Asset Management's NEO Position: Q1 2019 in Review

Smith Group Asset Management sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 99,800 shares — an estimated $1.26M sold.

Smith Group Asset Management first reported a position in NEO in Q4 2018 and held it in 1 quarter. The position peaked at $1.26M in Q4 2018. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

  • Smith Group Asset Management reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
  • Smith Group Asset Management sold 99,800 NeoGenomics shares in Q1 2019, an estimated $1.26M.
  • Smith Group Asset Management first reported a position in NeoGenomics in Q4 2018 and held it in 1 quarter.
  • Smith Group Asset Management's NeoGenomics position peaked at $1.26M in Q4 2018.
  • 235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on Smith Group Asset Management's 13F filing for Q1 2019, filed 10 May 2019.